Furthermore, the increased expression of CD21 (one of the EBV entry receptors) on the AChR-specific B cells of MG patients supports the contribution of EBV to the activation and expansion of autoreactive B cells in MG [181,182]. The gene discussed is CR2; the disease is myasthenia gravis.